Arbutus Biopharma Corporation (ABUS) dropped -5.04% or -0.3 to $5.65. It is close to 161341 shares traded, which is 84.94% compare to the average total volume 189937. The market cap of ABUS is $314.39 million. The year to date change is 9.17%. The 52 week price range is from $3.2 to $8.25. Price of ABUS have changed 9.17% during last week. It have changed 15.53% over last month, 15.53% over last 3 months, -0.83% over last 6 months and 77.61% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ABUS is 5.33. It is -5.66% below current price. The 200-day Moving Averages for ABUS is 5.20. It is -7.96% below current price. The 52-week High is 8.25. It is 46.02% from the current price. The 52-week Low is 3.2. It is -43.36% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of ABUS is 3.35 on 2018-04-13. Short % to float is 1.39%. There are some statistics of ABUS. It is has market cap $314.39 million. The share outstanding is 55.64 million. The average volume is 189937. The revenue is 8.17M. The gross profit is -36688000. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ABUS is -50.83%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ABUS is -33.26%.